Laboratory-based frailty index predicts health outcomes in systemic lupus erythematosus, suggesting an early screening tool.
An FI constructed exclusively from routinely collected laboratory variables can measure frailty and predict adverse outcomes in SLE. It may serve as a convenient screening tool to detect subclinical frailty and promote early risk mitigation in this population.
No takes yet. Share an insight, caveat, or question.
Burns et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: